Quantum-Si Inc (QSI)
1.75
+0.02
(+1.16%)
USD |
NASDAQ |
May 22, 16:00
1.75
0.00 (0.00%)
After-Hours: 20:00
Quantum-Si Enterprise Value: 9.912M for May 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 9.912M |
| May 20, 2024 | 15.58M |
| May 17, 2024 | 19.84M |
| May 16, 2024 | 28.35M |
| May 15, 2024 | 28.35M |
| May 14, 2024 | 24.09M |
| May 13, 2024 | 8.493M |
| May 10, 2024 | 5.657M |
| May 09, 2024 | 24.09M |
| May 08, 2024 | 19.84M |
| May 07, 2024 | 17.00M |
| May 06, 2024 | 25.51M |
| May 03, 2024 | 25.51M |
| May 02, 2024 | 14.17M |
| May 01, 2024 | 19.84M |
| April 30, 2024 | -7.106M |
| April 29, 2024 | 2.821M |
| April 26, 2024 | -1.434M |
| April 25, 2024 | -7.106M |
| April 24, 2024 | 1.403M |
| April 23, 2024 | 5.657M |
| April 22, 2024 | -5.688M |
| April 19, 2024 | -12.78M |
| April 18, 2024 | -21.29M |
| April 17, 2024 | -18.45M |
| Date | Value |
|---|---|
| April 16, 2024 | -2.852M |
| April 15, 2024 | -0.0156M |
| April 12, 2024 | 4.239M |
| April 11, 2024 | 22.68M |
| April 10, 2024 | 24.09M |
| April 09, 2024 | 32.60M |
| April 08, 2024 | 22.68M |
| April 05, 2024 | 22.68M |
| April 04, 2024 | 19.84M |
| April 03, 2024 | 25.51M |
| April 02, 2024 | 19.84M |
| April 01, 2024 | 26.93M |
| March 31, 2024 | 43.95M |
| March 28, 2024 | 21.55M |
| March 27, 2024 | 10.21M |
| March 26, 2024 | -6.803M |
| March 25, 2024 | -5.386M |
| March 22, 2024 | -3.968M |
| March 21, 2024 | 11.63M |
| March 20, 2024 | 11.63M |
| March 19, 2024 | 10.21M |
| March 18, 2024 | 13.04M |
| March 15, 2024 | -12.47M |
| March 14, 2024 | -6.803M |
| March 13, 2024 | 0.2852M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-128.80M
Minimum
Mar 10 2023
1.871B
Maximum
Jun 29 2021
156.69M
Average
19.84M
Median
Apr 02 2024
Enterprise Value Benchmarks
| Generation Bio Co | 6.230M |
| Viracta Therapeutics Inc | 15.97M |
| CERo Therapeutics Holdings Inc | -- |
| CEL-SCI Corp | 65.64M |
| AIM ImmunoTech Inc | 13.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.47M |
| Revenue (Quarterly) | 0.457M |
| Total Expenses (Quarterly) | 23.82M |
| EPS Diluted (Quarterly) | -0.14 |
| Gross Profit Margin (Quarterly) | 58.86% |
| Profit Margin (Quarterly) | -4.26K% |
| Earnings Yield | -37.14% |
| Normalized Earnings Yield | -42.94 |